Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography
Author(s) -
Act Trial Investigators
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.038943
Subject(s) - medicine , hazard ratio , dialysis , acute kidney injury , kidney disease , relative risk , confidence interval , placebo , randomization , contrast induced nephropathy , acetylcysteine , randomized controlled trial , cardiology , surgery , percutaneous coronary intervention , myocardial infarction , pathology , alternative medicine , biochemistry , chemistry , antioxidant
It remains uncertain whether acetylcysteine prevents contrast-induced acute kidney injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom